Temporary supply shortage for Adenoscan® (adenosine injection)


There is currently a temporary supply shortage for Adenoscan® (adenosine injection), which is produced by Astellas Pharma. This situation is expected to be resolved by the first quarter of 2013. Astellas is not withdrawing or recalling Adenoscan from the market. This shortage is due to unanticipated demand. Please contact the Astellas Medical Communications Department at 800-727-7003 if you have any medical questions. Your distributor may still have product available -- please contact your supplier for updated information. While this shortage exists, regadenoson or dipyridamole may be considered as alternative agents. For usage information, please view ASNC's Imaging Guidelines for Stress Protocols.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ